Orugallu Medicare Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 29-12-2024
- Paid Up Capital ₹ 2.31 Cr
as on 29-12-2024
- Company Age 23 Year, 9 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.43 M
as on 29-12-2024
- Satisfied Charges ₹ 3.00 M
as on 29-12-2024
- Revenue 12.81%
(FY 2022)
- Profit 226.24%
(FY 2022)
- Ebitda 85.72%
(FY 2022)
- Net Worth 13.79%
(FY 2022)
- Total Assets -3.04%
(FY 2022)
About Orugallu Medicare
The Corporate was formerly known as Orugallu Medicare Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 2.31 Cr.
The company currently has active open charges totaling ₹1.43 M. The company has closed loans amounting to ₹3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Nagapurapu Prasad, Eedula Kiranmai, and Venkata Takkallapalli serve as directors at the Company.
- CIN/LLPIN
U85110TG2002PTC038323
- Company No.
038323
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jan 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Warangal, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Orugallu Medicare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagapurapu Prasad  | Managing Director | 08-Jan-2002 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkata Takkallapalli | Director | 27-Feb-2013 | Current |
| Eedula Kiranmai | Director | 27-Feb-2013 | Current |
Financial Performance of Orugallu Medicare.
Orugallu Medicare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.81% increase. The company also saw a substantial improvement in profitability, with a 226.24% increase in profit. The company's net worth Soared by an impressive increase of 13.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orugallu Medicare?
In 2021, Orugallu Medicare had a promoter holding of 88.06% and a public holding of 11.94%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Jan 2021 | ₹0.36 M | Open |
Hdfc Bank Limited Creation Date: 05 Jan 2021 | ₹0.36 M | Open |
Hdfc Bank Limited Creation Date: 05 Jan 2021 | ₹0.35 M | Open |
How Many Employees Work at Orugallu Medicare?
Unlock and access historical data on people associated with Orugallu Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orugallu Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orugallu Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
